Renalytix Plc (AIM:RENX)
London · Delayed Price · Currency is GBP · Price in GBX 5.87
-0.28 (-4.55%)
Sep 25, 2026, 4:27 PM GMT
Renalytix Market Cap
Renalytix has a market cap or net worth of 37.14 million as of September 25, 2026. Its market cap has increased by 4.30% in one year.
Market Cap
37.14M
Enterprise Value
36.84M
Revenue
2.45M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.87
ChartMarket Cap Chart
Since November 6, 2018, Renalytix's market cap has decreased from 64.58M to 37.14M, a decrease of -42.50%. That is a compound annual growth rate of -6.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 37.14M | 44.03% |
| Dec 31, 2025 | 25.78M | -27.58% |
| Dec 31, 2024 | 35.60M | 129.87% |
| Dec 29, 2023 | 15.49M | -71.47% |
| Dec 30, 2022 | 54.30M | -87.89% |
| Dec 31, 2021 | 448.32M | 27.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 6, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Craneware | 350.96M |
| Optima Health | 267.59M |
| Diaceutics | 163.83M |
| MedPal AI | 50.13M |
| Cambridge Cognition Holdings | 13.04M |
| Feedback | 2.78M |
| Imaging Biometrics | 2.22M |
| Trellus Health | 172.05K |